Quality of life and radiotherapy in brain metastasis patients

Reports of Practical Oncology and Radiotherapy

Volumn 17, Issue 5, 2012, Pages 281-287

  Fernandez, Gonçalo ^a   Pocinho, Rute ^a   Travancinha, Catarina ^a   Netto, Eduardo ^a   Roldão, Margarida ^a  

^a Instituto Portugues de Oncologia de Lisboa   (Portugal)

Author keywords

Brain metastases; Quality of life; Radiotherapy; Whole brain radiotherapy

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; BRAIN METASTASIS; CALCULATION; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COGNITION; COMMUNICATION DISORDER; DROWSINESS; EUROPEAN ORGANIZATION OF RADIOTHERAPY TREATMENTS QOL QUESTIONNAIRE; FEMALE; HAIR LOSS; HEALTH STATUS; HUMAN; LIMB WEAKNESS; MALE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANK SUM TEST; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 84867710856     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2012.08.003     Document Type: Article

References (36)

1. Zhang X., Zhang W., Cao W.D., Cheng G., Liu B., Cheng J. A review of current management of brain metastases. Ann Surg Oncol 2011, 10.1245/s10434-011-2019-2.
2. Gravrilovic I., Posner J. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005, 75:5-14. 10.1007/s11060-004-8093-6.
3. Nieder C., Spanne O., Mehta M., Grosu A., Geinitz H. Presentation, patterns of care, and survival in patients with brain metastases, what has changed in the last 20 years?. Cancer 2011, 10.1002/cncr.25707.
4. Schouten L.J., Rutten J., Huveneers H.A., Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and the lung and melanoma. Cancer 2002, 94(10):2698-2705.
5. Ellis T., Neal T., Chan M. The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors. Int J Surg Oncol 2012, 10.1155/2012/952345.
6. Goetz P., Ebinu J., Roberge D., Zadeh G. Current standards in the management of cerebral metastases. Int J Surg Oncol 2012, 10.1155/2012/493426.
7. Scoccianti S., Ricardi U. Treatment of brain metastases: review of phase III randomized controlled trials. Radiother Oncol 2011, 10.1016/j.radonc.2011.08.041.
8. Berk L. An overview of radiotherapy trials for the treatment of brain metastases. Oncology 1995, 9(11):1205-1212.
9. Craighead P., Chan A. Defining treatment for brain metastases patients: nihilism versus optimism. Support Care Cancer 2010, 10.1007/s00520-010-1068-6.
10. Gaspar L., Scott C., Murray K., Murray K., Curan W. Validation of RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47(4):1001-1006.
11. Sperduto P., Berkey B., Gaspar L., Mehta M., Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Rad Oncol Biol Phys 2008, 70(2):510-514.
12. Nieder C., Nestle U., Motaref B., Walter K., Niewald M., Schnabel K. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?. Int J Rad Oncol Biol Phys 2000, 46(2):297-302.
13. Lutterbach J., Bartelt S., Ostertag C. Long-term survival in patients with brain metastases. J Cancer Res Clin Oncol 2002, 128:417-425. 10.1007/s00432-002-0354-1.
14. Gerrad G., Prestwich R., Edwards A., et al. Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol 2003, 15(7):422-428.
15. Addeo R., Caraglia M., Faiola V., et al. Concomitant treatment of brain metastases with whole brain radiotherapy and temozolamide is active and improves QoL. BMC Cancer 2007, 7:18. 10.1186/1471-2407-7-18.
16. Scott C., Suh J., Stea B., Nabid A., Hackman J. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral plus whole brain radiation therapy for brain metastases. Am J Clin Oncol 2007, 30(6):580-587.
17. Aaronson N., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
18. Fayers P.M. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 2011, 37:1331-1334.
19. Moinpour C.M., Feilq P., Metch B., Hayden K.A., Meykens F.L., Crowley J. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 1989, 81(7):485-495.
20. Yaneva M.P., Semerdijeva M.A. Assessment of the effect of palliative radiotherapy for cancer patients with intracranial metastases using EORTC-QoL-C30 questionnaire. Folia Med 2006, 48(2):23-29.
21. Wong J., Hird A., Zhang L., et al. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75(4):1125-1131.
22. Murray K.J., Scott C., Greenberg H.M., et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997, 39(3):571-574.
23. Steinmann D., Shafer C., Oorschot B., et al. Effects of radiotherapy for brain metastases on quality of life (QoL). Strahlenther Onkol 2009, 185:190-197. 10.1007/s00066-009-1904-0.
24. Wong J., Hird A., Kirou-Mauro A., Napolskikh J., Chow E. Quality of life in brain metastases radiation trials: a literature review. Curr Oncol 2008, 15(5):25-43.
25. Chow E., Davis L., Holden L., Tsao M., Danjoux C. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage 2005, 30:18-23. 10.1016/j.jpainsymman.2005.02.009.
26. Millar B.M., Bezjak A., Tsao M., Sturdza A., Laperriere N. Defining the impact and contribution of steroids in patients receiving whole-brain irradiation for cerebral metastases. Clin Oncol 2004, 16(5):339-344.
27. Ryken T., MecDermott, Robinson P., et al. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:103-114. 10.1007/s11060-009-0057-4.
28. Bezjak A., Adam J., Barton R., et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002, 38:487-496.
29. Lagerwaard F.J., Levendag P.C., Nowak P.J., Eijkenboom W.M., Hanssens P.E., Schmitz P.I. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43(4):795-803.
30. Niemec M., Glogowski M., Tyc-Szczepniak D., Wierzchowski M., Kepka L. Characteristics of long-term survivors of brain metastases from lung cancer. Rep Pract Oncol Radiother 2011, 16:49-53.
31. Rades D., Dunst J., Schild S.E. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008, 184(5):251-255.
32. Rades D., Dziggel L., Haatanen T., et al. Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys 2011, 80(4):1122-1127. 10.1016/j.ijrobp.2010.03.031.
33. Villa S., Weber C., Moretones C., et al. Validation of the new graded prognostic assessment scale for brain metastases: a multicenter prospective study. Radiat Oncol 2011, 6:23. 10.1186/1748-1748-717x-6-23.
34. Herman M.A., Tremont-Lukats I., Meyers C.A., et al. Neurocognitive and functional assessment of patients with brain metastases. Am J Clin Oncol 2003, 26:273-279.
35. Olson R., Tyldesley S., Carolan H., Parkinson M., Chhanabhai T., McKenzie M. Prospective comparison of the prognostic utility of the Mini Mental State examination and the Montreal Cognitive Assessment in patients with brain metastases. Support Care Cancer 2011, 19:1849-1855. 10.1007/s00520-010-1028-1.
36. Li J., Bentzen S.M., Renschler M., Mehta M.P. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 2007, 25:1260-1266.